Monitor for actual sales by the selling stockholders, as the flood of shares could pressure the stock price. The minimal exercise price of $0.0001 suggests the warrants were issued to incentivize investment rather than raise capital, indicating potential desperation. Watch for any commentary on cash runway in upcoming filings given the going concern warning.
Price Chart
Executive Summary
OnKure Therapeutics has filed an S-3 shelf registration to register 36.1 million shares of common stock for resale by selling stockholders, including 26.7 million shares and 9.4 million shares issuable upon exercise of pre-funded warrants. The company will not receive proceeds from the resale, but will receive $0.0001 per share if warrants are exercised. This represents significant potential dilution of approximately 89% of the current market cap.
Key Financial Metrics
Key Facts
- OnKure filed an S-3 shelf registration to register 36,144,595 shares for resale by selling stockholders
- The shares include 26,713,638 outstanding shares and 9,430,957 shares issuable upon exercise of pre-funded warrants
- The company will not receive proceeds from the resale of shares by selling stockholders
- The company will receive $0.0001 per share if the pre-funded warrants are exercised
- The registration follows a private placement in March 2026 where $150 million was raised
- The offering represents approximately 89% of the company's current $198 million market capitalization
- The audit report notes substantial doubt about the company's ability to continue as a going concern due to recurring losses
Financial Impact
Potential dilution of up to $176 million (89% of current market cap) if all registered shares are sold
Risk Factors
- Significant share dilution that could pressure the stock price
- Potential for selling stockholders to dump shares quickly, creating downward pressure
- Company's ability to continue as a going concern is in doubt according to auditors
- Minimal proceeds to company from warrant exercises despite large share issuance
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 7 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| S-3 Filing (Primary) | 0001193125-26-177093 |
| Document: d122209dexfilingfees.htm | 0001193125-26-177093 |
| Document: d122209dex51.htm | 0001193125-26-177093 |
| Document: d122209dex231.htm | 0001193125-26-177093 |
| Document: 0001193125-26-177093-index-headers.html | 0001193125-26-177093 |
| Document: 0001193125-26-177093-index.html | 0001193125-26-177093 |
| Document: 0001193125-26-177093.txt | 0001193125-26-177093 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 7, 2026 18d ago | SC 13G | $2.30 | awaiting T+60 | — | $2.44 (+6.09%) |
Aug 4, 2026 11w ago | 8-K | $4.16 | awaiting T+60 | — | $2.44 (−41.35%) |
Apr 24, 2026 26w ago | S-3 | $4.99 $4.32 | ▲ +13.43% | ▲ +18.20% | $2.44 (+51.10%) |
Apr 21, 2026 26w ago | DEFA14A | $5.01 $4.20 | ▼ −16.17% | ▼ −20.95% | $2.44 (−51.30%) |
Mar 23, 2026 31w ago | Insider Cluster | $3.98 $4.29 | ▲ +7.79% | ▼ −5.27% | $2.44 (−38.69%) |
Mar 12, 2026 32w ago | Press Release | $3.78 $4.40 | ▲ +16.40% | ▲ +4.79% | $2.44 (−35.45%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers